Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic.

Multidiscip Respir Med 2014 Feb 4;9(1). Epub 2014 Feb 4.

Department of Pulmonary Diseases, Ataturk University School of Medicine, Erzurum, Turkey.

Background: Pharmacologic therapies have an important role in the success of interventions for smoking cessation. This study aims to determine the efficacy of several pharmacologic treatments in patients who applied to a smoking cessation clinic.

Methods: This retrospective study includes 422 patients who presented to our smoking cessation clinic between January 2010 and June 2013, used the pharmacologic treatment as prescribed and completed the one-year follow-up period. All patients were assessed using the Fagerström Test for Nicotine Dependence (FTND) and received both behavioral therapy and pharmacotherapy. Patients' smoking status at one year was assessed by telephone interview.

Results: The patients were 24.3% female (103/422) and 75.7% male (319/422) with a mean age of 38 ± 10 years. Patients were divided into three groups: varenicline (166 patients), bupropion (148 patients) and nicotine replacement therapy (108 patients).The smoking cessation rates of these groups were 32.5%, 23% and 52.8%, respectively, and were statistically significant (p > 0.001). The overall success rate was 35%. Further analysis revealed that pharmacologic therapy (p > 0.001) and gender (p = 0.01) were factors that showed statistically significant effects on smoking cessation rates. Males had higher success rates than females. The overall relapse rate was 21.6% and the bupropion group showed the highest relapse rate among treatment groups. Lack of determination emerged as the most important factor leading to relapse.

Conclusion: Nicotine replacement therapy was found to be more effective at promoting abstinence from smoking than other pharmacologic therapies.

Download full-text PDF

http://dx.doi.org/10.1186/2049-6958-9-9DOI Listing
February 2014
Save 15% Survey

Similar Publications

Tobacco use and cessation in the context of ART adherence: Insights from a qualitative study in HIV clinics in Uganda.

Soc Sci Med 2021 Feb 17;273:113759. Epub 2021 Feb 17.

Department of Health Sciences, Faculty of Sciences, University of York, York, YO10 5DD, UK.

Sub-Saharan Africa carries a disproportionate burden of human immunodeficiency virus (HIV). Tobacco use amongst people living with HIV is higher than in the general population even though it increases the risk of life-threatening opportunistic infections including tuberculosis (TB). Research on tobacco use and cessation amongst people living with HIV in Africa is sparse and it is not clear what interventions might achieve lasting cessation. Read More

View Article and Full-Text PDF
February 2021

How does the use of flavored nicotine vaping products relate to progression towards quitting smoking? Findings from the 2016 and 2018 ITC 4CV Surveys.

Nicotine Tob Res 2021 Feb 25. Epub 2021 Feb 25.

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Windsor Walk, Denmark Hill, London, UK.

Introduction: There is limited research on the role of flavors in nicotine vaping products (NVPs) in relation to smoking. We examined patterns of flavor use in NVPs in relation to progression towards quitting.

Methods: Data come from 886 concurrent users of NVPs (at least weekly) and cigarettes who were first surveyed in 2016 and then successfully recontacted in 2018 as part of the ITC 4CV Surveys conducted in Australia, Canada, England and the United States. Read More

View Article and Full-Text PDF
February 2021

Daily support and negative control during a quit attempt in single-smoking couples.

Health Psychol 2021 Mar;40(3):207-216

Department of Health Psychology, University Medical Center Groningen, University of Groningen.

Objective: Research has shown a beneficial influence of partner support on smoking cessation. Previous studies mainly focused on support and neglected negative behaviors. Less is known about differences in support perceptions between partners. Read More

View Article and Full-Text PDF

Smoking exposure in pack-years predicts cutaneous manifestations and damage in systemic lupus erythematosus.

Lupus 2021 Feb 24:961203321995257. Epub 2021 Feb 24.

Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

Objective: To examine the impact of cumulative smoking in pack-years on systemic lupus erythematosus (SLE) cutaneous manifestations and damage.

Methods: Our cohort study included 632 adult SLE patients at an academic center, meeting 1997 ACR or 2012 SLICC classification criteria. Outcomes were: (1) cutaneous SLICC Damage Index (SDI), (2) ACR and SLICC criteria. Read More

View Article and Full-Text PDF
February 2021

Factors Associated With Increased Complications in Patients With BRCA Gene Mutations Undergoing Reconstructive Breast Surgery.

Plast Surg Nurs 2021 Jan-Mar 01;41(1):43-50

Nieves Vanaclocha, MD, is a plastic surgeon at the Breast Pathology Functional Unit, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Reconstructive breast surgery after bilateral prophylactic mastectomy in patients who carry a mutation of the breast cancer (BRCA) gene has been increasing. Undergoing risk-reducing breast surgery can be of great benefit to young patients who have a high risk of developing breast cancer. There is little available evidence about the rate of complications in these patients and which factors are related to increased complications. Read More

View Article and Full-Text PDF
February 2021